China CAMC Engineering Co (002051) Fair Value & Analysis
Industrials · CN · Market cap 14.3B CNY
Fair value as of: Jun 25, 2026
Analysis
China CAMC Engineering Co (002051) currently trades at ¥13.23, while our model-based Fair Value estimate is ¥8.75 — implying the stock looks roughly 33.9% overvalued today. We read business quality at 80/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
China CAMC Engineering Co., Ltd. engages in construction, project management, machine operation, and maintenance business. It is involved in surveying and design, planning consulting, financing and investment, procurement and supply of equipment activities. The company also offers design consultation services and engineering contracting services. In addition, it provides passenger cableways, logistics warehousing, lifting machinery, and environmental protection equipment services. Additionally, it is involved in turnkey projects constructions related business. It serves medical care and health, civil construction, airport logistics, energy engineering, data centers, big science and other fields. The company was founded in 2001 and is based in Beijing, China. China CAMC Engineering Co., Ltd. is a subsidiary of China National Machinery Industry Corporation.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is China CAMC Engineering Co (002051) undervalued?
What is the fair value of 002051?
What is the quality score of 002051?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.